Latest Research

A Framework of Care in Multiple Sclerosis, Part 1

Scott D. Newsome, DO, MSCS;Philip J. Aliotta, MD, MSHA, CHCQM, FACS;Jacquelyn Bainbridge, PharmD;Susan E. Bennett, PT, DPT, EdD, NCS, MSCS;Gary Cutter, PhD;Kaylan Fenton, CRNP, APNP, MSCN;Fred Lublin, MD;Dorothy Northrop, MSW, ACSW;David Rintell, EdD;Bryan D. Walker, MHS, PA-C;Megan Weigel, DNP, ARNP-C, MSCN;Kathleen Zackowski, PhD, OTR, MSCS;David E. Jones, MD

November 1st 2016

Antidepressant Drug Treatment in Association with Multiple Sclerosis Disease-Modifying Therapy

Matthew M. Mirsky, MS;Ruth Ann Marrie, MD, PhD;Alexander Rae-Grant, MD, FRCPC

November 1st 2016

Comorbidity in Multiple Sclerosis

Ruth Ann Marrie, MD, PhD

November 1st 2016

Editorial - Volume 18, Issue 5 - September 2016

Francois Bethoux, MD

September 1st 2016

Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies

Stacey S. Cofield, PhD;Robert J. Fox, MD;Tuula Tyry, PhD;Amber R. Salter, PhD;Denise Campagnolo, MD, MS

September 1st 2016

Correction of Footdrop Due to Multiple Sclerosis Using the STIMuSTEP Implanted Dropped Foot Stimulator

Paul N. Taylor, PhD;Ingrid A. Wilkinson Hart, PhD;Mansoor S. Khan, FRCS(Plast);Diana E.M. Slade-Sharman, FRCS(Plast)

September 1st 2016

The Transition to Secondary Progressive Multiple Sclerosis

Freya Davies, MRCGP;Fiona Wood, PhD;Katherine E. Brain, PhD;Michelle Edwards, PhD;Rhiannon Jones, BSc;Rachel Wallbank, BSc;Neil P. Robertson, MD;Adrian Edwards, PhD

September 1st 2016

A Qualitative Study of Multiple Health Behaviors in Adults with Multiple Sclerosis

Matthew A. Plow, PhD;Meghan Golding, BS

September 1st 2016

Exercise Training in Progressive Multiple Sclerosis

Lara A. Pilutti, PhD;John E. Paulseth, MD;Carin Dove, MD;Shucui Jiang, MD, PhD;Michel P. Rathbone, MD, PhD;Audrey L. Hicks, PhD

September 1st 2016

Letter to the Editor: The Emerging Role of Pharmacists in the Multidisciplinary Care of Patients with Multiple Sclerosis

Jordan Schultz, PharmD, MSCS, BCACP;Cindy Weber, RN;John Kamholz, MD, PhD

September 1st 2016

Severity Grading in Multiple Sclerosis

Robert Charlson, MD;Joshua Herbert, BA;Ilya Kister, MD

September 1st 2016

Editorial - Volume 18, Issue 4 - July 2016

Francois Bethoux, MD

Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis

Pamela Newland, RN, PhD, CMSRN;Louise Flick, DrPH, MSN, MPE;Hong Xian, PhD;Florian P. Thomas, MD, MA, PhD

Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data

Sarah J. Shoemaker, PhD, PharmD;Alyssa Pozniak, PhD;Louise Hadden, BA

The Perceived Deficits Questionnaire

Lauren B. Strober, PhD;Allison Binder, BS;Olga M. Nikelshpur, PhD;Nancy Chiaravalloti, PhD;John DeLuca, PhD

Coping with Multiple Sclerosis Scale

Holly A. Parkerson, MA;Melissa D. Kehler, PhD;Donald Sharpe, PhD;Heather D. Hadjistavropoulos, PhD

NAPS-MS - Volume 18, Issue 4 - July 2016

Richard A. Sater, MD, PhD;Mark Gudesblatt, MD;Kiren Kresa-Reahl, MD;David W. Brandes, MD;Pamela Sater, MPAS

A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis

Theodore R. Brown, MD;Virginia I. Simnad, MD

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a

June Halper, MSN, APN-C, MSCN, FAAN;Diego Centonze, MD;Scott D. Newsome, DO;DeRen Huang, MD, PhD;Christopher Robertson, PharmD;Xiaojun You, PhD;Guido Sabatella, MD;Vladimir Evilevitch, MD;Leslie Leahy, PhD

Editorial - Volume 18, Issue 3 - May 2016

Francois Bethoux, MD

Abstracts from the 30th Annual Meeting of the Consortium of Multiple Sclerosis Centers

Development and Feasibility of an Evidence-Based Patient Education Program for Managing Fatigue in Multiple Sclerosis

Maria Janina Wendebourg, ;Lena Katharina Feddersen, MSc;Stephanie Lau, ;Sascha Köpke, PhD;Rona Moss-Morris, PhD;Christoph Heesen, MD;Jana Pöttgen, PhD

Analysis of Diagnoses Associated with Multiple Sclerosis–Related In-Hospital Mortality Using the Premier Hospital Database

Frank R. Ernst, PharmD, MS;Jennifer Pocoski, PharmD, MPH;Gary Cutter, PhD;David W. Kaufman, ScD;Dirk Pleimes, MD

Critical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis

Prudence Plummer, PhD, BPhysio(Hons)

Symptomatic Management of Multiple Sclerosis–Associated Tremor Among Participants in the NARCOMS Registry

William Meador, MD;Amber R. Salter, MPH;John R. Rinker, MD

Evaluation of a Fatigue Self-Management Program for People with Multiple Sclerosis

Hilda Mulligan, PhD;Amanda Wilkinson, PhD;Amelia Barclay, BPhty;Hayley Whiting, BPhty;Christelle Heynike, BPhty;Jessie Snowdon, BPhty, PGCertClinRehab

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

Jonathan Calkwood, MD;Timothy Vollmer, MD;Robert J. Fox, MD, FAAN;Ray Zhang, PhD;Mark Novas, MD;Sarah I. Sheikh, MD, MRCP;Vissia Viglietta, MD, PhD

Examining the Relationship Between Family Caregivers' Emotional States and Ability to Empathize with Patients with Multiple Sclerosis

Sepideh Pooyania, MD;Michelle Lobchuk, RN, PhD;Wanda Chernomas, RN, PhD;Ruth Ann Marrie, MD, PhD

Editorial - Volume 18, Issue 2 - March 2016

Francois Bethoux, MD

Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis

Setareh Ghahari, PhD;Susan J. Forwell, PhD

...

12 13 14 15 16 17 18 19 20

...